Correction to: Efficacy, safety and drug survival of thioguanine as maintenance treatment for inflammatory bowel disease: a retrospective multi-centre study in the United Kingdom

BMC Gastroenterol. 2022 Apr 26;22(1):208. doi: 10.1186/s12876-021-01992-2.

Ahmed B Bayoumy^#^{1

2

3

4}, Elsa L S A van Liere^#^{5

6

7

8}, Melek Simsek⁹, Ben Warner⁶, Aathavan Loganayagam⁷, Jeremy D Sanderson⁶, Simon Anderson⁶, Jonathan Nolan⁸, Nanne K de Boer⁹, Chris J J Mulder⁵, Azhar Ansari⁸

¹ Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre, Amsterdam, The Netherlands. a.b.bayoumy@amsterdamumc.nl.
² Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK. a.b.bayoumy@amsterdamumc.nl.
³ Department of Gastroenterology, Queen Elizabeth Hospital, Woolwich, UK. a.b.bayoumy@amsterdamumc.nl.
⁴ Department of Gastroenterology, Surrey and Sussex NHS, Easy Surrey Hospital, Surrey, UK. a.b.bayoumy@amsterdamumc.nl.
⁵ Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre, Amsterdam, The Netherlands.
⁶ Department of Gastroenterology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
⁷ Department of Gastroenterology, Queen Elizabeth Hospital, Woolwich, UK.
⁸ Department of Gastroenterology, Surrey and Sussex NHS, Easy Surrey Hospital, Surrey, UK.
⁹ Department of Gastroenterology and Hepatology, Amsterdam UMC, VU University Medical Centre, AG&M Research Institute, Amsterdam, The Netherlands.

^# Contributed equally.

No abstract available

Publication types